Calculus Capital Limited / Stargrove Pictures Limited UK Creative Content EIS Fund

Hardman & Co

Why invest

Positives

  • Strategy: To invest in a portfolio of unquoted media companies that will generate meaningful IP.

Issues

  • Time to invest: The target time to invest of 15 months is longer than for some other EIS funds.

The Investment Manager

Positives

  • Team: One of the longest standing managers in the VCT/EIS area, Calculus has a highly experienced and stable team.

Issues

  • Past performance: While Calculus has a substantial and credible record from investing in other sectors, this is a new area for the team. However, the addition of Stargrove brings sector experience.

Nuts & bolts

  • Offer period: Closing dates are quarterly on last Fridays of October, January, April and June.
  • Diversification: The aim is to invest in at least six companies.
  • Valuation: Investors will receive valuations twice a year. Industry guidelines will be used, with two auditors examining the figures.

Specific issues

  • Fees: Mixture of direct fees and charged via the investee companies.
  • Performance fee: 20% on gains over a hurdle rate of 1.2x total capital invested.

Risks

  • Risk mitigation: Although a new sector for the Manager, Calculus will use its established investment processes and has brought in a specialist advisor in Stargrove.
  • Target return: Overall, the strategy is medium-risk relative to other EIS/VCT products, with the target capital return of 2.0x towards the top end of what we’d expect for that risk category.

DOWNLOAD THE FULL REPORT

Share on:

Latest Company News

XP Factory delivering double-digit revenue growth and strategic momentum (LON:XPF)

XP Factory CEO discusses strong interim results, highlighting a 13% increase in group sales, robust performances from Escape Hunt and Boom Battle Bar, improved EBITDA margins, and a new £20 million revolving credit facility with HSBC.

Elemental Royalty CEO David Cole on merger synergies and global royalty growth

Elemental Royalty Corporation's David Cole discusses the transformative merger between Elemental Altus and EMX Royalty. Cole highlights the company’s value-driven strategy, a diversified portfolio of over 300 mineral royalty assets across 20 countries, and the key role of discovery optionality in driving long-term returns.

RM Plc Strengthens Transformation Strategy with Equity Raise – Singer Capital Markets

RM Plc raises equity to fund RM Ava and strategic transformation, enabling divestments and digital assessment growth, says Singer Capital Markets.

Serco appoints Mark Reid as Group Chief Financial Officer

Serco Group plc has announced the appointment of Mark Reid as Group Chief Financial Officer and Executive Director, effective 6 March 2026.

Derwent London secures planning approval for Brixton hotel scheme

Derwent London has received unanimous planning approval for a hotel led redevelopment at Blue Star House in Brixton SW9.

GSK secures FDA approval for Exdensur in severe eosinophilic asthma

GSK plc has received US FDA approval for Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in patients aged 12 and over.

    Search

    Search